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INTRODUCTION
Matriptase is a member of the type II transmembrane serine protease group, which is characterized by the presence of an N-terminal cytoplasmic domain followed by a signal anchor transmembrane domain and an extracellular domain, including a C-terminal serine protease catalytic domain ( Fig. 1 ) (1) (2) (3) (4) (5) (6) . Matriptase is first synthesized as a zymogen comprising 855 amino acid residues in human, mouse and rat enzymes. The matriptase zymogen undergoes cleavage between Arg614 and Val615 (activation cleavage) and the disulfide-linked two-chain fully active enzyme is generated ( Fig. 1) (1) (2) (3) (4) (5) (6) . Two-chain matriptase exhibits activity with trypsin-like specificity and can cleave and activate a number of proteins, including pro-hepatocyte growth factor (HGF) and the precursor of a membrane-bound serine protease, prostasin (7) (8) (9) . The potential substrates, abundant expression in epithelial cells and in keratinocytes and characteristic phenotypes in matriptase gene-disrupted mice, suggest that the enzyme plays important roles in the establishment and maintenance of epithelial and epidermal barriers (1, 3, (10) (11) (12) .
( Fig. 1) The activation cleavage of matriptase zymogen is believed to occur through a mechanism requiring its own catalytic triad (His656, Asp711 and Ser805) (1, 2, (13) (14) (15) .
For instance, recombinant (or r-) forms of full-length matriptase, in which any residues of the catalytic triad are changed to an alanine residue, are unable to undergo activation when expressed exogenously in BT549 breast cancer cells (13) . To date, the zymogen molecules have been postulated to undergo transactivation by which a zymogen interacts with another zymogen, producing the activation cleavage of each zymogen (1, 13) . If so, matriptase zymogen should exert protease activity. We have found that (i) a pseudozymogen form of r-matriptase comprising the entire extracellular domain forms a catalytic triad analogous to His-Asp-Ser of trypsin-like serine proteases and that (ii) the r-pseudozymogen effectively hydrolyses a peptide substrate, acetyl-L-Lys-L-Thr-L-Lys-L-Gln-L-Leu-L-Arg-4-methyl-coumaryl-7-amide (hereinafter abbreviated as Ac-KTKQLR-MCA), whose sequence shares some sequence similarities with the activation-cleavage site of this protease ( Fig. 1) (16) . In addition, the r-pseudozymogen exhibited optimal Ac-KTKQLR-MCA-hydrolysing activity under mildly acidic and low ionic strength conditions (e.g., 5 mM NaCl and pH 6.0), under which matriptase zymogen endogenously expressed in a human mammary epithelial line 184 A1N4 undergoes activation with optimal efficiency (17) (18) (19) . Our findings reinforce the concepts that the zymogen molecules can activate themselves by self-catalysed proteolysis and thus that this protease serves as an initiator molecule of a protease cascade that is involved in the maintenance of epithelial and epidermal integrity (1, 3) .
It should be noted, however, that the zymogen activation seems to be mediated predominantly by two-chain molecules. Indeed, the Ac-KTKQLR-MCA-hydrolysing activity was higher for the corresponding two-chain r-matriptase than for the r-pseudozymogen (16) .
Matriptase has an extracellular non-catalytic stem domain comprising a sea urchin sperm protein-enteropeptidase-agrin (SEA) domain, followed by two tandem repeats of complement proteases C1r/C1s-urchin embryonic growth factor-bone morphogenetic protein (CUB) domain and four tandem repeats of a low-density lipoprotein receptor class A (LDLRA) domain ( Fig. 1) (1-6). Lin and co-workers have proposed the intimate involvement of the matriptase stem domain in its zymogen activation (13, 19) .
For instance, a site-directed mutant of full-length matriptase (Gly149Asn), which was designed to escape post-translational cleavage between Gly149 and Ser150 within the SEA domain (refer to Fig. 1 ), was unable to undergo activation (13) . A possible explanation for this is that, upon cleavage within the SEA domain, the matriptase zymogen undergoes a conformational change or reorientation on the membrane surface that makes the protease susceptible to activation cleavage. The CUB and LDLRA repeats were also shown to affect the zymogen activation (13, 19) . However, the definitive roles of these repeats in the zymogen activation remain unclear. We have shown that (i) the matriptase second CUB domain (CUB domain II) serves as an additional site for interaction with a physiological inhibitor of this protease, HGF activator inhibitor type-1 (HAI-1), which contains two protease-inhibitory Kunitz domains, and that (ii) the interaction between CUB domain II and HAI-1 facilitates the primary inhibitory interaction between the enzyme and inhibitor (i.e., interaction between the SPCD of two-chain matriptase and the first Kunitz domain) ( Fig. 1) (20) .
This finding raises the possibility that CUB domain II may suppress zymogen activation by accelerating the rate of inhibition of the two-chain matriptase by HAI-1.
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The purpose of the present study was to gain insights into the role(s) of CUB and LDLRA repeats in the activation of matriptase zymogen. To date, structural requirements of matriptase zymogen for its activation cleavage have been studied upon transient expression of the membrane-bound forms of r-matriptase in cultured cells (13-15, 21, 22) . In the context of membrane-bound forms, internal deletions and point mutations showed differential effects on the activation cleavage (13) . For example, full-length r-matriptase bearing a mutation in its LDLRA repeat (tyrosine replacement of aspartic acid residues comprising the calcium cage in each domain) rarely underwent activation, whereas a truncated variant lacking the repeat did it to a similar extent as in full-length, wild-type (WT) r-matriptase (13) . Expression studies using soluble, truncated forms of r-matriptase could be expected to solve contradictory conclusions regarding the roles of internal domains (CUB and LDLRA repeats). In addition, the activation behaviors of soluble variants in cellulo would provide a coherent interpretation of the in vitro results obtained using soluble, truncated, pseudozymogen forms of r-matriptase (pro-CLS-, pro-LS-and pro-S-mat EK-A variants, Fig. 1 ) (20) . For these reasons, we prepared plasmids for the expression of secreted variants of r-matriptase and investigated whether the r-matriptase variants undergo activation cleavage when expressed in COS-1 monkey kidney cells. Our in cellulo results provided suggestive evidence that the CUB repeat had an inhibitory effect, whereas the LDLRA repeat had a promoting effect, on zymogen activation. In vitro experiments using the pseudozymogen forms of r-matriptase showed that the LDLRA repeat increased the protease activity of matriptase zymogen. To our knowledge, this is the first report showing how CUB and LDLRA repeats of matriptase participate in its zymogen activation. (Pro41-Ser441) and pSec-HAI-1 IK1L (Thr154-Ser370)] have already been constructed using pSecTag2/HygroB vector (Invitrogen, Carlsbad, CA) (20, 23) .
MATERIALS AND METHODS
The plasmid for the expression of a secreted variant of r-matriptase comprising amino acids Gln210-Val855 was created as follows. A DNA fragment was amplified by polymerase chain reaction (PCR) with KOD-plus-DNA polymerase (Toyobo, Osaka, Japan), 5-TCAGGACAACAGCTGCA-3 and 5-CTATACCCCAGTTTGCTCT-3 as the forward and reverse primers, respectively, and a plasmid for the expression of full-length, WT rat matriptase (pcDNA-WT-matriptase) (15, 22) as the template. The PCR product was phosphorylated with T4 polynucleotide kinase and ligated into the SmaI-linearized pT7blue2 vector (Novagen) (pT7-pro-CLS-mat). pT7-pro-CLS-mat was digested with KpnI and BamHI, and the resulting fragment was ligated into pSec-pro-CLS-mat EK-A from which a fragment produced by digestion with KpnI and BamHI had been removed. This plasmid was designated pSec-pro-CLS-mat WT .
Plasmids for the expression of secreted variants of r-matriptase comprising amino acids
Cys453-Val855 and Asp603-Val855 were made using the same method except that 5-ATGCCCAGGGATGTTCAT-3 and 5-TGACTGTGGGCTGCGATCCTTTAC-3, respectively, were used as forward primers. The plasmids were designated pSec-pro-LS-mat WT and pSec-pro-S-mat WT . The expression plasmids (pSec-pro-CLS-mat S805A , pSec-pro-LS-mat S805A and pSec-pro-S-mat S805A ) were created by the same methods as those adopted for the creation of pSec-pro-CLS-mat WT , pSec-pro-LS-mat WT and pSec-pro-S-mat WT , except that a plasmid for the expression of a full-length variant of r-matriptase bearing an alanine instead of serine at position 805 (pcDNA-S805A/matriptase) (15) was used as the template in the PCR. The sequences of the expression plasmids constructed in the present study were determined in both directions using the dideoxynucleotide chain-termination method, as described previously (5) .
Transfection of Expression Plasmids into COS-1 Cells and Sample Preparation -The
procedure for the transfection of constructs into COS-1 cells using Lipofectamine2000™ (Invitrogen) has been described previously (15, 21) . Note that each of the six plasmids for the expression of r-matriptase variants (2.4 g) was co-transfected with pSecTag2/hygroB (2.4 g) or pSec-HAI-1 NIK1LK2 (2.4 g). Cells (1:3,000 dilution) for 2 h at 22C. The blots were washed with TBST, and the protein bands were visualized using an ECL ® detection system (GE Healthcare, Tokyo, Japan).
Analysis of Expression Products of r-Matriptase and r-HAI-1 Variants by

SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) and Western Blotting
The r-HAI-1 variant and the non-activated forms of r-matriptase variants were probed using HRP-conjugated S-protein (hereinafter called S-protein-HRP) (Novagen, Madison, WI) diluted in Can Get Signal ® Solution II (1:3,000 dilution).
Preparation of Pseudozymogen Forms of r-Matriptase and HAI-1 IK1L -We have
established Chinese hamster ovary (CHO)-K1 cell lines that stably express pro-CLSmat EK-A , pro-LS-mat EK-A or pro-S-mat EK-A (20) . In the present study, we established a CHO-K1 cell line expressing HAI-1 IK1L using the same method as described previously (23) .
The stably transfected cells were cultured in a 75 cm 2 plastic flask (Asahi Techno Glass) as described previously (23) . After reaching confluence, cells were washed three times with PBS, and 10 ml of Ham's F12 without foetal bovine serum was added to the flask. After 48 h of incubation, the conditioned medium was collected, and fresh serum-free medium was added. This was repeated until half of the cells had peeled off.
The collected media were centrifuged immediately at 3,000 g for 10 min at 22C, and the resulting supernatants were stored at -20C until use. For purification, 300 ml of the conditioned media was collected into three flasks. After thawing, the media were pooled and concentrated to 2.5 ml by ultrafiltration using an Amicon ® Ultra-15 membrane filter (50,000 MWCO for pro-CLS-mat EK-A , 30,000 MWCO for pro-LS-mat EK-A and HAI-1 IK1L , and 10,000 MWCO for pro-S-mat EK-A , Millipore). The concentrated medium was subjected to gel filtration in a buffer [25 mM HEPES (pH 7.5) containing 145 mM NaCl and 0.1% Triton X-100] (hereinafter called purification buffer) using a PD-10 column (GE Healthcare) with an elution volume of 3.5 ml. The gel filtrate was divided equally, and each part was transferred to a 2.0-ml microcentrifuge tube in which a 62.5-l slurry of immobilized S-protein was included. The tubes were incubated for 30 min at 22C with rocking. After brief centrifugation, the supernatants were incubated again with immobilized S-protein as described above. The precipitated slurries were pooled (250 l) and washed three times with 1.5 ml of purification buffer and twice with 1.5 ml of 10 mM HEPES (pH 7.5) containing 5 mM NaCl and 0.01% Triton X-100 (hereinafter called elution buffer). To elute these r-matriptase molecules, the washed slurry was transferred with 500 l of elution buffer containing 200 M of synthetic S-Tag peptide (KETAAAKFERQHIDS, synthesized by BEX, Tokyo, Japan) to a spin column (Attoprep™, 0.22-m pore size, Atto, Tokyo, Japan) and centrifuged at 5,000 g for 1 min at 22C. The eluate was subjected to gel filtration in elution buffer using an NAP-5 column (GE Healthcare) with an elution volume of 1.0 ml and stored at -20C until use.
The concentration of each r-matriptase variant was measured semi-quantitatively as follows. Various amounts of r-matriptase variants and HAI-1 IK1L and Perfect Protein Marker™ protein size marker (Novagen), in which each protein was fused to an S-Tag and the concentration of each marker was known, were subjected to reducing SDS-PAGE (12% polyacrylamide) followed by Western transfer. The blots were probed with S-protein-HRP. The X-ray films were scanned digitally, and the signal intensities of protein bands were analysed by densitometry as described previously (23) . The concentrations of each r-matriptase variant and HAI-1 IK1L were calculated by comparing the signal density of each band of interest with the 50-kDa protein contained as the protein marker.
Preparation of r-Matriptase Variants Corresponding to the Two-Chain Form and
Determination of Their Ac-KTKQLR-MCA-Hydrolysing Activities -To generate r-matriptase variants corresponding to the two-chain form of matriptase (hereinafter called CLS-mat, LS-mat and S-mat), a 500-l portion of the elution buffer containing 50 nM pro-CLS-mat EK-A , pro-LS-mat EK-A or pro-S-mat EK-A was incubated for 24 h at 22C with a recombinant form of enteropeptidase (hereinafter called r-EK) (Novagen).
The final concentration of r-EK was 1 unit/ml. After incubation, the solution (activation mixture) was stored at -20C until use. The concentrations of CLS-mat, LS-mat and S-mat in the activation mixture were evaluated by reducing SDS-PAGE (12% polyacrylamide) and Western blotting using Spr992 (22) . The signal density of a 28-kDa band produced from the SPCD part of CLS-mat, LS-mat or S-mat was compared with that of a 90-kDa band produced from pro-CLS-mat EK-A , whose concentration had been determined as described above. The reaction mixtures containing the pseudozymogen forms of r-matriptase variants were incubated for 72 h. To prevent water evaporation within the tube, the incubation was conducted using a temperature controller (PC805-MI, ASTEC, Fukuoka, Japan). 
Ac
Hydrolysis of Ac-KTKQLR-MCA by pro-CLS-mat EK-A , pro-LS-mat EK-A or pro-S-mat EK-
RESULTS
Identification of Secreted Variants of r-Matriptase and the Detection Methods -To
assess the roles of CUB and LDLRA repeats in the activation of matriptase zymogen by in cellulo experiments, we prepared plasmids for the expression of secreted variants of r-matriptase: pro-CLS-mat WT comprising the CUB and LDLRA repeats and the SPCD; pro-LS-mat WT comprising the LDLRA repeat and SPCD; and pro-S-mat WT comprising only the SPCD (Fig. 1) . The superscript WT in these r-matriptase variants reflects that each of them has both the activation-cleavage site and the catalytic triad, identical to full-length, WT rat matriptase. In the present study, the expression plasmids for their respective active-site mutants (i.e., mutant in which a serine residue corresponding to the active-site residue Ser805 of matriptase was changed to an alanine residue), pro-CLS-mat S805A , pro-LS-mat S805A and pro-S-mat S805A , were also prepared (Fig. 1) .
The co-transfection of cDNAs encoding HAI-1 has been shown to be required for successful detection of full-length, WT r-matriptase in transient expression experiments with cultured cells, including COS-1 cells (13, 15, 21, 22) . In the absence of HAI-1, the r-matriptase inadvertently activated in the intracellular environment appears to undergo extensive degradation via a self-catalysed mechanism, thus being rarely detectable (21) .
Upon co-expression with HAI-1, both zymogen and two-chain forms of the r-matriptase were detectable (13, 15, 21, 22) . It is also noted upon co-expression with HAI-1 in COS-1 cells that (i) the activation cleavage of the r-matriptase can occur on the surface of cells and that (ii) both the non-activated and activated forms of r-matriptase frequently undergo ectodomain shedding, thereby being detected predominantly in the conditioned medium (15, 21, 22) . In the present study, we transfected the plasmids to induce the expression of secreted variants of r-matriptase into the cells with or without a plasmid for the expression of a secreted variant of r-HAI-1 comprising all of the extracellular domain (pSec-HAI-1 NIK1LK2 , Fig. 1) (21, 23) and investigated whether the r-matriptase variants undergoing activation cleavage (i.e., cleavage after an arginine residue corresponding to matriptase Arg614) can be detected in media conditioned by transfected cells. The occurrence of activation cleavage was assessed to determine whether a 28-kDa protein is immunostained on a Western blot with an anti-matriptase SPCD antibody (Spr992) following reducing SDS-PAGE (refer to Fig. 1) (21, 22) . The r-matriptase variants that did not undergo cleavage after an arginine residue corresponding to matriptase Arg614 were analysed by reducing SDS-PAGE and Western blotting with Spr992 or with S-protein-HRP (note that an S-Tag is fused to the N-terminus of each variant). HAI-1 NIK1LK2 has been detected as a 59-kDa band by reducing SDS-PAGE and Western blotting with S-protein-HRP (21) .
Analysis of the Expression of pro-CLS-mat WT and its Respective Active-site Mutant -
First, we analysed the expression of pro-CLS-mat WT and pro-CLS-mat S805A (Fig. 2) .
When a sample of media conditioned by COS-1 cells transfected with
pSec-pro-CLS-mat WT alone was probed with Spr992, no signal at the position corresponding to 28 kDa was produced (left panel, lane CLS-WT). A similar result was obtained for a medium sample of cells transfected with pSec-pro-CLS-mat WT and pSec-HAI-1 NIK1LK2 (left panel, lane CLS-WT + HAI-1). Using Spr992 as a probe, several protein bands were produced from medium samples of transfected cells (especially dense at the 80-to 90-kDa positions; also refer to the data for COS-1 cells transfected with pSecTag2/HygroB vector alone shown in Supplementary Fig. S1 , lane Mock). These signals are derived from unknown proteins secreted by COS-1 cells (21) . ( Fig. 2 and Supplementary Fig. S1 )
Analysis of the Expression of pro-LS-mat WT and its Respective Active-site Mutant -We
next analysed the expression of pro-LS-mat WT and pro-LS-mat S805A (Fig. 3) . When a sample of media conditioned by cells transfected with pSec-pro-LS-mat WT 
Analysis of the Expression of pro-S-mat WT and its Respective Active-site Mutant -We
present the data for the expression of pro-S-mat WT and pro-S-mat S805A in Fig. 4 . When the sample of media conditioned by cells transfected with pSec-pro-S-mat WT pSec-pro-S-mat WT produced 40-, 36-and 31-kDa bands in a Western blot probed with S-protein-HRP (right panel, lanes S-WT and S-WT and HAI-1). Judging from the molecular masses, the three bands may represent pro-S-mat WT species. We also note that the appearance of the three pro-S-mat WT species may be explained by cleavage by signal peptidases of COS-1 cells at different sites.
When probed with Spr992 or S-protein-HRP, 40-, 36-and 31-kDa bands were visualized in samples of cells transfected with pSec-pro-LS-mat S805A alone and in samples of cells transfected with pSec-pro-LS-mat S805A and pSec-HAI-1 NIK1LK2 (left and right panels, lanes S-S805A and S-805A + HAI-1). The appearance of the three pro-S-mat S805A species indicates that the active-site mutant also undergoes cleavage by signal peptidases of COS-1 cells at different sites. The results obtained using cells transfected with pSec-pro-S-mat S805A indicate that the pro-S-mat WT variant undergoes activation cleavage via a mechanism requiring the active-site serine residue.
( Fig. 4) 
Comparison of the Degrees of Activation and Levels of Expression of pro-CLS-, pro-LSand pro-S-mat WT Variants -The degrees of activation cleavage and levels of expression
of pro-CLS-, pro-LS-and pro-S-mat WT variants were analysed in a Western blot ( Supplementary Fig. S1 ). We could not successfully evaluate the levels of expression of r-matriptase variants when each of them was expressed alone. Upon co-expression with HAI-1 NIK1LK2 , it is evident that the level of expression of pro-S-mat WT was greater than that of pro-LS-mat WT . In addition, the level of expression of pro-CLS-mat WT was not significantly lower than that of pro-LS-mat WT . Therefore, it seems unlikely that the level of expression seriously affects the activation frequency at least in experiments with COS-1 cells. In addition, the levels of HAI-1 NIK1LK2 detected did not differ substantially irrespective of the type of r-matriptase variants co-expressed, suggesting that interaction frequencies of the variants with the r-HAI-1 do not differ substantially.
Hydrolysis of Ac-KTKQLR-MCA by Pseudozymogen Forms of r-Matriptase -We have
produced pseudozymogen forms of r-matriptase using CHO-K1 cells as the host for expression (20, 23) . Of these, a variant comprising all of the extracellular domain was found to exhibit substantial Ac-KTKQLR-MCA-hydrolysing activity (16) . In the present study, we investigated the Ac-KTKQLR-MCA-hydrolysing activities of the pro-CLS-, pro-LS-and pro-S-mat EK-A variants (Fig. 1) . Five amino acid residues needed for activation cleavage of this protease (Thr-Lys-Gln-Ala-Arg614) were changed to those suitable for cleavage by enteropeptidase (Asp-Asp-Asp-Asp-Lys) in any of the variants. This allowed for in vitro generation of an N-terminal valine residue corresponding to matriptase Val615 by treatment with r-EK (20, 23) . Each of the r-matriptase variants after treatment with r-EK (CLS-mat, LS-mat and S-mat)
hydrolysed Ac-KTKQLR-MCA with a reaction rate of about 2 nM s -1 . This is consistent with the observation that the stem domain of matriptase in the two-chain form has no substantial effect on the hydrolysis of peptidyl-MCA substrates (25, 26) . The pro-CLS-, pro-LS-and pro-S-mat EK-A variants not treated with r-EK can be used as models for matriptase zymogen.
In the present study, we prepared a secreted variant of r-HAI-1 comprising the internal, first Kunitz and LDLRA domains using CHO-K1 cells (HAI-1 IK1L , Fig. 1 ).
This r-HAI-1 variant was found to be most effective at inhibiting a two-chain r-matriptase variant (23) . To avoid the detection of activities derived from CLS-mat, LS-mat and S-mat occurring inadvertently during incubation, the HAI-1 IK1L variant was included in the reaction mixtures. We confirmed that the HAI-1 IK1L produced in CHO-K1 cells exhibited a matriptase-inhibition activity similar to the variant produced in COS-1 cells (23) .
The pro-CLS-, pro-LS-and pro-S-mat EK-A variants hydrolysed Ac-KTKQLR-MCA. The k cat , K m and k cat /K m values are shown in Table 1 . We note that the k cat /K m values of the pro-CLS-and pro-LS-mat EK-A variants were similar but more than 10 times higher than that of the pro-S-mat EK-A variant. These results suggest that the CUB repeat has no substantial effect on the expression of zymogen activity and that the LDLRA repeat contributes considerably to the expression of zymogen activity.
( Table 1) 
DISCUSSION
The CUB domain is a widely occurring module in proteolytic enzymes or proteins that are involved in developmental processes, and the domains in certain proteases appear to be essential for recognition of natural substrates (27, 28) . In matriptase, the second CUB domain has been postulated to serve as an additional site for interaction with HAI-1 to downregulate its own catalytic activity (20) . r-Matriptase variants with the second CUB domain (e.g., CLS-mat) are inhibited by HAI-1 NIK1LK2 with high efficiency, whereas those without the domain (e.g., LS-mat and S-mat) are inhibited with low efficiency (20) . In our transient expression experiments, a protein band at the 28-kDa position was detected from a sample of cells transfected with pSec-pro-LS-mat WT and pSec-HAI-1 NIK1LK2 but not from that of cells transfected with pSec-pro-CLS-mat WT and pSec-HAI-1 NIK1LK2 . Our interpretation is that the activated pro-CLS-mat WT (hereinafter called two-chain pro-CLS-mat WT ) undergoes frequent inactivation by HAI-1 NIK1LK2 , and thus the activation cleavage of pro-CLS-mat WT by two-chain pro-CLS-mat WT occurs rarely. By contrast, the activated pro-LS-mat WT (hereinafter called two-chain pro-LS-mat WT ) is inactivated rarely by the r-HAI-1 variant, and thus the activation cleavage of pro-LS-mat WT by two-chain pro-LS-mat WT occurs efficiently.
It seems likely that the pro-CLS-mat WT variant exerts protease activity to generate two-chain pro-CLS-mat WT . This is supported by the observations that (i) the sample of cells transfected with pSec-CLS-mat WT alone rarely produced a protein band at the 90-kDa position, whereas that of cells transfected with pSec-CLS-mat S805A alone did and that (ii) pro-CLS-mat EK-A hydrolysed Ac-KTKQLR-MCA to a comparable extent as did pro-LS-mat EK-A . In the absence of the r-HAI-1, two-chain pro-CLS-mat WT occurring in the intracellular environment might degrade pro-CLS-mat WT and two-chain pro-CLS-mat WT progressively, and thus both species would be rarely detected. A similar phenomenon may occur in the cells transfected with pSec-LS-mat WT alone and in those transfected with pSec-S-mat WT alone. Yet, it is uncertain why an activated form of matriptase was detected from medium samples of COS-1 cells transfected with a plasmid for expression of full-length, WT r-matriptase and pSec-HAI-1 NIK1LK2 (21) but not from those transfected with pSec-pro-CLS-mat WT and pSec-HAI-1 NIK1LK2 . One possible explanation is that the CUB domain-accelerated interaction with the r-HAI-1 occurs slowly and inefficiently in a cell membrane-associated state of two-chain matriptase, whereas it does rapidly and efficiently in the soluble state.
The LDLRA domain is about 40 amino acids, is biologically ubiquitous, and is found in several proteins. In general, this domain is thought to be involved in protein-protein interaction (29) . In the present study, we found that Ac-KTKQLR-MCA-hydrolysing activity was higher in pro-LS-mat EK-A than in pro-S-mat EK-A . This strongly suggests that one of the important roles of the LDLRA repeat of matriptase is to increase the zymogen activity, thereby facilitating the zymogen-catalysed activation cleavage of zymogen. Our transient expression experiments also support this idea. The pro-S-mat WT species were detected in the sample from cells transfected with pSec-pro-S-mat WT alone, whereas pro-LS-mat WT was rarely detected in the sample from cells transfected with pSec-pro-LS-mat WT alone. In addition, when co-expressed with HAI-1 NIK1LK2 , the pro-S-mat WT species were detected in a sample from cells transfected with pSec-pro-S-mat WT and pSec-HAI-1 NIK1LK2 , whereas the pro-LS-mat WT was hardly detected in the sample from cells transfected with pSec-pro-LS-mat WT and pSec-HAI-1 NIK1LK2 . In other words, the vast majority of pro-LS-mat WT underwent activation cleavage, whereas less than half of pro-S-mat WT did.
The LDLRA domain of matriptase has been modelled based on the structure of the fifth LDL-binding domain of the LDL receptor (30, 31) . Interestingly, the fourth LDLRA domain of matriptase was predicted to interact with the surface of its SPCD opposite to the active-site cleft (30) . In addition, matriptase zymogen appears to form a catalytic triad analogous to mature trypsin-like serine proteases (16, 32) . It is tempting to speculate that the putative intramolecular interaction between the LDLRA repeat and SPCD within a matriptase zymogen facilitates the conformational change required for forming mature form-like structure. The CUB repeat does not appear to exert a substantial effect on the expression of zymogen activity. The Ac-KTKQLR-MCAhydrolysing activity did not differ substantially between pro-CLS-mat EK-A and pro-LS-mat EK-A .
In summary, we have provided insights into the roles of CUB and LDLRA repeats of matriptase in its zymogen activation. The CUB repeat might facilitate interaction of its SPCD of the two-chain enzyme with HAI-1, thereby contributing to the suppression of the activation cleavage of zymogen catalysed by the active enzyme. The LDLRA repeat appears to have a critical effect on the expression of zymogen activity. These non-catalytic domains of matriptase might be organized in ways that allow this protease to serve as the most upstream regulator of the protease cascade that controls epithelial and epidermal integrity. The kinetic value is expressed as a mean ± SD of triplicate determinations. 
Figure legends
